Objectives We aimed to determine the optimal cut-off of the immunochemical faecal occult blood test (iFOBT) by using cost- effectiveness analysis. Methods A total of 22,672 subjects aged 50 years or older were invited to have an uptake of iFOBT. We collected data from screen-detected cases for the cut-off above 100 ng/mL and obtained interval cancers from a nationwide cancer registry for a cut-off below 100 ng/mL. We found a total of 65 colorectal cancer ( CRC) cases, including 43 detected by screen and 22 diagnosed between screens (interval cases). The optimal cut-off was first determined by receiver operating characteristics (ROC) curve analysis. Formal economic evaluation was further applied to identifying the optimal cut-off by assessin...
Colorectal cancer (CRC) takes a second and fourth position in the incidence and mortality lists resp...
Colorectal cancer (CRC) takes a second and fourth position in the incidence and mortality lists resp...
BACKGROUND & AIMS: Biomarker assays could increase the accuracy of noninvasive detection of colorect...
Background & Aims: Two European randomized trials (N = 30,000) compared guaiac fecal occult blood te...
Objectives Through the National Health Service Bowel Cancer Screening Programme (BCSP), men and wome...
OBJECTIVES: To evaluate the direct costs of first and repeat colorectal cancer screening by immuno...
Background: Organised programmes for colorectal cancer screening demand a high burden of medical and...
International audienceObjective: To assess the cost-effectiveness of colorectal cancer screening usi...
Comparability of cost-effectiveness of colorectal cancer (CRC) screening strategies is limited if he...
Background: The aim of this study is to compare the cost- effectiveness of screening with stool DNA ...
The incremental costs and effects of annual faecal occult blood test screening in Australia were mod...
Background: Colorectal cancer screening can decrease morbidity and mortality. However, there are wid...
BACKGROUND: The cutoff of semi-quantitative immunochemical faecal occult blood tests (iFOBTs) influe...
Background The ColonCancerCheck screening program for colorectal cancer (CRC) in Ontario, Canada, is...
Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based...
Colorectal cancer (CRC) takes a second and fourth position in the incidence and mortality lists resp...
Colorectal cancer (CRC) takes a second and fourth position in the incidence and mortality lists resp...
BACKGROUND & AIMS: Biomarker assays could increase the accuracy of noninvasive detection of colorect...
Background & Aims: Two European randomized trials (N = 30,000) compared guaiac fecal occult blood te...
Objectives Through the National Health Service Bowel Cancer Screening Programme (BCSP), men and wome...
OBJECTIVES: To evaluate the direct costs of first and repeat colorectal cancer screening by immuno...
Background: Organised programmes for colorectal cancer screening demand a high burden of medical and...
International audienceObjective: To assess the cost-effectiveness of colorectal cancer screening usi...
Comparability of cost-effectiveness of colorectal cancer (CRC) screening strategies is limited if he...
Background: The aim of this study is to compare the cost- effectiveness of screening with stool DNA ...
The incremental costs and effects of annual faecal occult blood test screening in Australia were mod...
Background: Colorectal cancer screening can decrease morbidity and mortality. However, there are wid...
BACKGROUND: The cutoff of semi-quantitative immunochemical faecal occult blood tests (iFOBTs) influe...
Background The ColonCancerCheck screening program for colorectal cancer (CRC) in Ontario, Canada, is...
Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based...
Colorectal cancer (CRC) takes a second and fourth position in the incidence and mortality lists resp...
Colorectal cancer (CRC) takes a second and fourth position in the incidence and mortality lists resp...
BACKGROUND & AIMS: Biomarker assays could increase the accuracy of noninvasive detection of colorect...